News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,625 Results
Type
Article (8019)
Company Profile (139)
Press Release (475371)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166760)
Career Advice (305)
Deals (25740)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238244)
Policy (17922)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (483)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33154)
ALS (103)
Alzheimer's disease (971)
Antibody-drug conjugate (ADC) (258)
Approvals (10353)
Artificial intelligence (314)
ASCO (159)
Autoimmune disease (202)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (106)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (135)
Brain cancer (28)
Breast cancer (503)
Cancer (3594)
Cardiovascular disease (214)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (473)
Cervical cancer (34)
Clinical research (47785)
Collaboration (1221)
Commercialization (2)
Compensation (1402)
Complete response letters (34)
COVID-19 (752)
CRISPR (63)
C-suite (724)
Cystic fibrosis (84)
Data (5552)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (337)
Diagnostics (4165)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (149)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (161)
Earnings (73183)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87512)
Executive appointments (686)
FDA (12327)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (900)
Gene editing (125)
Generative AI (9)
Gene therapy (311)
GLP-1 (287)
Government (940)
Grass and pollen (2)
Guidances (280)
Healthcare (9308)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (62)
Immunology and inflammation (98)
Immuno-oncology (55)
Indications (153)
Infectious disease (938)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (247)
Interviews (41)
IPO (12380)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (2)
Liver cancer (44)
Longevity (15)
Lung cancer (499)
Lymphoma (245)
Machine learning (27)
Management (3)
Manufacturing (519)
Marketing (7)
MASH (117)
Medical device (8644)
Medtech (8775)
Mergers & acquisitions (14364)
Metabolic disorders (694)
mRNA (50)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (214)
Neuropsychiatric disorders (38)
Neuroscience (1800)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (219)
Opinion (10)
Ovarian cancer (157)
Pain (170)
Pancreatic cancer (191)
Parkinson's disease (197)
Partnered (11)
Patents (460)
Patient recruitment (490)
Peanut (31)
People (41160)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15441)
Phase 2 (21338)
Phase 3 (14372)
Pipeline (6777)
Policy (18)
Postmarket research (1570)
Preclinical (6528)
Press Release (34)
Prostate cancer (188)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (562)
Real estate (3019)
Recruiting (6)
Regulatory (14735)
Reports (16)
Research institute (579)
Resumes & cover letters (45)
Rett syndrome (40)
RNA editing (5)
RSV (47)
Schizophrenia (99)
Series A (151)
Series B (119)
Service/supplier (4)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (50)
Vaccines (314)
Venture capital (17)
Weight loss (72)
Women's health (76)
Date
Today (54)
Last 7 days (365)
Last 30 days (1177)
Last 365 days (19109)
2026 (11164)
2025 (19251)
2024 (22988)
2023 (26538)
2022 (34593)
2021 (37167)
2020 (33468)
2019 (23276)
2018 (17468)
2017 (18765)
2016 (17917)
2015 (24264)
2014 (21683)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20333)
Location
Africa (227)
Alabama (72)
Alaska (2)
Arizona (295)
Arkansas (11)
Asia (17858)
Australia (2092)
California (11623)
Canada (3068)
China (507)
Colorado (468)
Connecticut (397)
Delaware (205)
Europe (24586)
Florida (1741)
Georgia (366)
Hawaii (3)
Idaho (46)
Illinois (687)
India (45)
Indiana (310)
Iowa (13)
Japan (392)
Kansas (99)
Kentucky (30)
Louisiana (25)
Maine (25)
Maryland (1167)
Massachusetts (7654)
Michigan (300)
Minnesota (548)
Mississippi (4)
Missouri (79)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2562)
New Mexico (12)
New York (2756)
North Carolina (1242)
North Dakota (4)
Northern California (5798)
Ohio (270)
Oklahoma (14)
Oregon (15)
Pennsylvania (2209)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4820)
Tennessee (114)
Texas (1879)
United States (37850)
Utah (351)
Vermont (1)
Virginia (149)
Washington D.C. (38)
Washington State (904)
West Virginia (1)
Wisconsin (73)
483,625 Results for "skinvisible inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Skinvisible Submits Innovative Obesity Patent for Advanced Transdermal Treatment
Skinvisible Pharmaceuticals, Inc., an innovative pharmaceutical research and development company, announced a major advancement in the battle against obesity.
May 29, 2024
·
4 min read
Skinvisible Expands Obesity Patent Application for Transdermal Delivery
Skinvisible Pharmaceuticals, Inc. (OTCQB:SKVI), an innovative topical / transdermal pharmaceutical research and development company, today announced the filing of a second patent application for its groundbreaking Invisicare® technology and its transdermal delivery of obesity and glucose-controlling agents.
June 24, 2024
·
5 min read
Skinvisible Announces Significant Progress in Licensee’s Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome
Skinvisible, Inc. (“Skinvisible”) (OTCQB:SKVI) is excited to share a promising update on the ongoing clinical trials conducted by its licensee, Quoin Pharmaceuticals, Inc. (“Quoin”) (NASDAQ:QNRX).
February 14, 2024
·
4 min read
Press Releases
Promising Data on Transdermal Obesity Formulations Announced by Skinvisible
July 12, 2024
·
4 min read
Policy
Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug
Skinvisible, Inc., is pleased to announce that its licensee Quoin Pharmaceuticals, Inc., has received U.S. FDA acceptance of its Investigational New Drug application for its licensed formulation which uses Skinvisible’s Invisicare® proprietary drug delivery technology.
June 6, 2022
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Press Releases
Therma Bright Inc. Completes Debt Settlements
July 30, 2026
·
3 min read
Press Releases
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
July 30, 2026
·
6 min read
Press Releases
Axogen, Inc. Reports Second Quarter 2026 Financial Results
July 29, 2026
·
19 min read
1 of 48,363
Next
